Case | 25 May 2022

Protected: Setterwalls has advised Trill Impact in connection with a private placement in Cinclus Pharma

Responsive image

This content is password protected. To view it please enter your password below:

Contact:

Ola Grahn, Martin Levinsohn

Practice areas:

Private Equity, Life Sciences

  • This field is for validation purposes and should be left unchanged.

Do you want to get in touch with us?

Please fill out the form and we will contact you as soon as possible.

Related news

Setterwalls has advised Integrum AB in connection with a rights issue of approximately SEK 42.7 million

Case | 3 December 2025

Setterwalls has advised Integrum AB in connection with a rights issue of approximately SEK 42.7 million

Read more
Setterwalls Life Sciences Report November 2025

Article | 24 November 2025

Setterwalls Life Sciences Report November 2025

Read more
Two Judgments on Sales of Alcoholic Beverages in Sweden on Producers’ Sites – Opening Hours Are Not Required to Match Those of Systembolaget

Article | 24 November 2025

Two Judgments on Sales of Alcoholic Beverages in Sweden on Producers’ Sites – Opening Hours Are Not Required t...

Read more
Load more